Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3811-3820 of 4090 results

Catalogue Number:

PX-TA1027

Category:

G

Proteo Genix logo

Romilkimab Biosimilar – Anti-IL13/ IL4 mAb – Research Grade

Target: IL13/ IL4
Target Alias Name: Romilkimab/Romilkimab/IL13/ IL4/anti-IL13/ IL4
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: [VH-VH' Gamma1 + VL-VL' kappa (bispecific)
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1502

Category:

G

Proteo Genix logo

Romilkimab Biosimilar – Anti-IL13/ IL4 mAb – Research Grade

Target: IL13/ IL4
Target Alias Name: Romilkimab/SAR156597/huTBTI3_2_1/IL13/ IL4/anti-IL13/ IL4
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: [VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1800

Category:

G

Proteo Genix logo

Romlusevimab Biosimilar – Anti-Spike RBD mAb – Research Grade

Target: Spike RBD
Target Alias Name: Romlusevimab/BRII 198/ BRII-198/ BRII198/Spike RBD/anti-Spike RBD
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda2
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1281

Category:

G

Proteo Genix logo

Romosozumab Biosimilar – Anti-SOST mAb – Research Grade

Target: SOST
Target Alias Name: Romosozumab/785A070802/AMG 785/CDP-7851/romosozumab-aqqg/sclerostin Ab/SOST/anti-SOST
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1235

Category:

G

Proteo Genix logo

Rontalizumab Biosimilar – Anti-IFNA1 mAb – Research Grade

Target: IFNA1
Target Alias Name: Rontalizumab/RhuMAB IFNalpha/IFNA1/anti-IFNA1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1446

Category:

G

Proteo Genix logo

Rosmantuzumab Biosimilar – Anti-RSPO3 mAb – Research Grade

Target: RSPO3
Target Alias Name: Rosmantuzumab/OMP-131R10/RSPO3/anti-RSPO3
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1881

Category:

G

Proteo Genix logo

Rosnilimab Biosimilar – Anti-PDCD1 mAb – Research Grade

Target: PDCD1
Target Alias Name: Rosnilimab//PDCD1/anti-PDCD1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1712

Category:

G

Proteo Genix logo

Rosopatamab Biosimilar – Anti-FOLH1 mAb – Research Grade

Target: FOLH1
Target Alias Name: Rosopatamab/HUJ-591/ HUJ591-GS/ IMMUNOGLOBULIN G1/ ANTI-(HUMAN PROSTATE-SPECIFIC MEMBRANE ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HUJ591 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HUJ591 .KAPPA.-CHAIN/ DIMER/ MAB MURINE (IGG2A) ANTI Q04609 (FOLH1_HUMAN) (HUJ591)/ MAB MURINE (IGG2A) ANTI Q04609 (FOLH1_HUMAN)/FOLH1/anti-FOLH1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1397

Category:

G

Proteo Genix logo

Rovalpituzumab Biosimilar – Anti-DLL3 mAb – Research Grade

Target: DLL3
Target Alias Name: Rovalpituzumab//DLL3/anti-DLL3
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1216

Category:

G

Proteo Genix logo

Rovelizumab Biosimilar – Anti-ITGAL/ CD11a/ ITGB2/ CD18 mAb – Research Grade

Target: ITGAL/ CD11a/ ITGB2/ CD18
Target Alias Name: Rovelizumab/Hu23F2G/ITGAL/ CD11a/ ITGB2/ CD18/anti-ITGAL/ CD11a/ ITGB2/ CD18
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo